Pharmafile Logo

The art of changing behaviour with virtual technology

April 13, 2016 |  

- PMLiVE
In April’s issue of PME, Ella Nuttall (Health Psychology Specialist at Lucid Group) explains how changing behaviour requires a combination of science and art. She outlines how the impact of new technologies has increased the breadth of mechanisms (the ‘art’) through which science-based, behaviour-changing interventions are delivered. Of particular note is the emergence of virtual technology as a mechanism to support medical education – such as the first virtual reality operation due to take place this month – viewable live across the world.

Ella reveals how Lucid has successfully incorporated a variety of virtual technologies in their behaviour-changing medical education programmes: from live-link sessions of medical procedures to projection technology to portray a virtual patient. Ella discusses the impact and rationale behind using a virtual mannequin with Emma Herring (Lucid Account Director), who led the project.

To learn more about using virtual technologies and how it has helped Lucid to change behaviour and improve patient outcomes you can read the full article 
here.

This content was provided by Lucid Group Communications Limited

Company Details

 Latest Content from  Lucid Group Communications Limited 

Lucid Strategy Consulting: Empowering Next-Generation Solutions for Life Sciences

Lucid Group announces the evolution of its consulting division, Lucid Strategy Consulting, setting a new standard for deep-domain, knowledge-led consulting solutions for life sciences. We have brought together two Lucid...

My Lucid journey from PMW to Head of Medical

Working in Medical Communications has never been about the nine to five. Fusing science and language in the service of both clients and patients, this is typically a fast paced...

Listen, learn and lift off

In April’s PME, Danny Buckland has been talking to industry leaders about launch excellence in the featured article, Listen, learn and lift off.Buckland points out that pandemic storms have changed the...

Launch excellence

In the April edition of PME, Cheryl Harrison Doyle, Global Asset Strategy Director at Lucid Group discusses the need to take a more considered, outcomes-led approach when launching new medicines...

Meet The Lucid Group Talent Team

Meet our talent team, they're here to help and transform your career.We have some exciting roles at all levels in account management and medical writing.If you choose to take your...

Extraordinary lives: advancing change in rare diseases (Part 2)

In support of Rare Disease Day, we’re excited to launch part 2 of our video series; Extraordinary lives: advancing change in rare diseases.Why is raising awareness of rare diseases so...

Extraordinary lives: advancing change in rare diseases (Part 2)

In support of Rare Disease Day, we're excited to launch part 2 of our video series; Extraordinary lives: advancing change in rare diseases.Why is raising awareness of rare diseases so...

Extraordinary lives: advancing change in rare diseases (Part 1)

Rare Disease Day is all about raising awareness and generating change for the 300 million people worldwide living with a rare disease. The global rare disease community and its supporters come together on...

My Journey into MedComms #LucidLife

I began as a medical writer after almost a decade working in medical publishing as a production editor. Whilst working in publishing, I was exposed to lots of different writing...